Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation

Leukemia and Lymphoma

Volumn 42, Issue 3, 2001, Pages 291-299

  Ohyashiki, K ^a   Iwama, H ^a   Yahata, N ^a   Tauchi, T ^a   Kawakubo, K ^a   Shimamoto, T ^a   Ohyashiki, J H ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Genomic instability; Myelodysplastic syndromes; Telomerase; Telomere

Indexed keywords

MICROSATELLITE DNA; TELOMERASE;

ACUTE LEUKEMIA; APOPTOSIS; CELL; CYTOGENETICS; CYTOPENIA; DISEASE COURSE; DYNAMICS; DYSPLASIA; ENZYME ACTIVITY; GENETIC STABILITY; HEMATOPOIETIC CELL; HUMAN; MICROSATELLITE INSTABILITY; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENESCENCE; TELOMERE;

EID: 0034903102     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109064585     Document Type: Review

References (32)

1. Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes
2. Clinical implications of chromosomal abnormalities in 401 patients with MDS: A multicentric study in Japan
3. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases
4. International scoring system for evaluating prognosis in Myelodysplastic syndrome
5. Telomeres shortening during aging of human fibroblasts
6. Telomere length predicts replicative capacity of human fibroblasts
7. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes
8. Telomerase activity in human cancer
9. Telomeres and telomerase in human cancer
10. Correlating telomerase activity levels with human neuroblastoma outcomes
11. Length of telomeric repeats in neuroblastoma: Correlation with prognosis and other biological characteristics
12. Proposal for the classification of the myelodysplastic syndrome
13. Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome
14. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows
15. Apoptosis and its significance in MDS: Controversies revisited
16. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
17. Telomerase activity in preleukemia and acute myelogenous leukemia
18. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes
19. Telomerase activity in normal leukocytes and in hematologic malignancies
20. Replication errors in hematological neoplasias: Genomic instability in progression of disease is different among different types of leukemia
21. Telomere length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals
22. Microsatellite instability is an early genetic event in myelodysplastic syndrome but is infrequent and not associated with TGF-beta receptor type II gene mutation
23. Stability of microsatellites in myeloid neoplasias
24. Rarity of microsatellite alterations in acute myeloid leukaemia
25. Microsatellite instability during the progression of acute myelocytic leukaemia
26. Telomere length in myelodysplastic syndromes
27. The relationship between telomere length and therapy-associated cytogenetic responses in chronic myeloid leukemia
28. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression
29. Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia: Based on our experience
30. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes
31. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
32. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit